Clinical Trial: Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine

Brief Summary: The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.

Detailed Summary:
Sponsor: National Institute on Drug Abuse (NIDA)

Current Primary Outcome:

  • Safety
  • Cardiovascular responses


Original Primary Outcome:

  • Cocaine craving
  • pharmacokinetic assessment
  • Safety
  • Cardiovascular responses
  • Abuse Liability


Current Secondary Outcome:

  • Cocaine craving
  • pharmacokinetic assessment
  • Psychological Effects of Cocaine
  • Abuse Liability
  • Mood and personality assessments


Original Secondary Outcome:

  • Psychological Effects of Cocaine
  • Mood and personality assessments


Information By: National Institute on Drug Abuse (NIDA)

Dates:
Date Received: December 13, 2005
Date Started: August 2005
Date Completion:
Last Updated: January 11, 2017
Last Verified: August 2016